Editorial: Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment?

Thomas H. Brannagan, Shanna K. Patterson

Research output: Contribution to journal › Editorial

6 Scopus citations

Original language	English
Pages (from-to)	319-321
Number of pages	3
Journal	Expert Review of Clinical Immunology
Volume	6
Issue number	3
DOIs	https://doi.org/10.1586/eci.10.23
State	Published - May 2010
Externally published	Yes

Access to Document

@article{b9ccbb4b22c34cb9acf50f70b2b6e422,

title = "Editorial: Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment?",

author = "Brannagan, {Thomas H.} and Patterson, {Shanna K.}",

year = "2010",

month = may,

doi = "10.1586/eci.10.23",

language = "English",

volume = "6",

pages = "319--321",

journal = "Expert Review of Clinical Immunology",

issn = "1744-666X",

publisher = "Taylor and Francis Ltd.",

number = "3",

}

TY - JOUR

T1 - Editorial

T2 - Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment?

AU - Brannagan, Thomas H.

AU - Patterson, Shanna K.

PY - 2010/5

Y1 - 2010/5

UR - http://www.scopus.com/inward/record.url?scp=77952014915&partnerID=8YFLogxK

U2 - 10.1586/eci.10.23

DO - 10.1586/eci.10.23

M3 - Editorial

C2 - 20441416

AN - SCOPUS:77952014915

SN - 1744-666X

VL - 6

SP - 319

EP - 321

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

IS - 3

ER -